论文信息 - LBA-08Results of a phase 1b study of the selective BRAF V600 inhibitor encorafenib in combination with cetuximab alone or cetuximab + alpelisib for treatment of patients with advanced BRAF-mutant metastatic colorectal cancer - 字舞流文

LBA-08Results of a phase 1b study of the selective BRAF V600 inhibitor encorafenib in combination with cetuximab alone or cetuximab + alpelisib for treatment of patients with advanced BRAF-mutant metastatic colorectal cancer

S. Jaeger | J. Schellens | H. Lenz | J. Tabernero | R. Yaeger | M. Schuler | Z. Wainberg | J. Bendell | Sanjay Sharma | M. Lolkema | T. Yoshino | J. Faris | Yasuhide Yamada | J. Delord | A. Spreafico | T. Demuth | F. Eskens | Emin Avşar | A. Chatterjee | E. Élez | R. V. Geel | Y. Yamada | Sunil Sharma